Real-world EGFR testing in patients with advanced EGFRm NSCLC in Belgium (REVEAL)

被引:0
|
作者
Cuppens, K. [1 ]
Lodewyckx, L. [2 ]
Demedts, I. [3 ]
Decoster, L. [4 ]
Colinet, B. [5 ]
Deschepper, K. [6 ]
Janssens, A. [7 ]
Pauwels, P. [8 ]
Galdermans, D. [9 ]
Pieters, T. [10 ]
机构
[1] Virga Jesse Ziekenhuis, Dept Pulmonol & Thorac Oncol, Hasselt, Belgium
[2] AstraZeneca Nv Sa, Dept Med, Oncol, Groot Bijgaarden, Belgium
[3] AZ Delta, Dept Pulm Dis, Roeselare, Belgium
[4] UZ Brussel, Oncol Ctr, Dept Med Oncol, Jette, Belgium
[5] Grand Hop Charleroi, Dept Pneumol & Thorac Oncol, Charleroi, Belgium
[6] AZ Nikolaas, Pneumol, St Niklaas, Belgium
[7] Univ Hosp Antwerp UZA, Dept Pulmonol & Thorac Oncol, Edegem, Belgium
[8] Univ Hosp Antwerp UZA, Pathol Dept, Edegem, Belgium
[9] ZNA Middelheim, Pneumol, Antwerp, Belgium
[10] Catholic Univ Louvain, Clin Univ St Luc, Dept Pulmonol, Brussels, Belgium
关键词
D O I
10.1016/j.annonc.2020.08.1306
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2000P
引用
收藏
页码:S1117 / S1117
页数:1
相关论文
共 50 条
  • [1] Real-world treatment patterns of patients with locally advanced/metastatic EGFRm NSCLC in Belgium (REVEAL)
    Cuppens, K.
    Lodewyckx, L.
    Demedts, I.
    Decoster, L.
    Colinet, B.
    Deschepper, K.
    Janssens, A.
    Galdermans, D.
    Pieters, T.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S871 - S872
  • [2] Real-world EGFR testing patterns among US patients with advanced NSCLC
    Vanderpoel, Julie
    Pericone, Chris
    He, Jinghua
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [3] South Korean real-world treatment patterns in patients with EGFRm NSCLC
    Lee, J. C.
    Kim, Y-C.
    Lee, S. Y.
    Yoo, S. S.
    Davis, K.
    Nagar, S. P.
    Sawyer, W.
    Yu, N.
    Taylor, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1403 - S1403
  • [4] EGFR Testing Practices, Treatment Choice and Clinical Outcomes in Advanced NSCLC in a Real-World Setting
    Subramanian, J.
    Gregg, J.
    Berktas, M.
    Jiang, Z.
    Li, J.
    Taylor, A.
    Leighl, N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S438 - S439
  • [5] Afatinib followed by osimertinib in patients with EGFR mutation-positive (EGFRm plus ) advanced NSCLC: Updated data from the GioTag real-world study
    Hochmair, M. J.
    Morabito, A.
    Hao, D.
    Yang, C-T.
    Soo, R.
    Yang, J. C-H.
    Gucalp, R.
    Halmos, B.
    Wang, L.
    Golembesky, A.
    Maerten, A.
    Cufer, T.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [6] First-line and beyond: West Midlands real-world data for EGFR mutant (EGFRm) NSCLC
    Powell, R.
    Kussaibati, R.
    Khan, A.
    Sivapalasuntharam, A.
    Wilson, P.
    Chowdhary, R.
    Murukesh, N.
    Jain, A.
    Iqbal, M.
    Ghafoor, Q.
    Baijal, S.
    [J]. LUNG CANCER, 2020, 139 : S60 - S61
  • [7] Real-World Data of Osimertinib in Patients with Metastatic EGFRm plus NSCLC who Progressed on First-Line EGFR TKIs
    Ma, J.
    Tan, S. H.
    Yin, D.
    Tran, A.
    Tan, D.
    Ang, M.
    Takano, A.
    Lim, K. H. T.
    Kanesvaran, R.
    Jain, A.
    Rajasekaran, T.
    Tan, E.
    Lim, D. W.
    Ng, Q. S.
    Tan, W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S627 - S628
  • [8] Real-World Characteristics and Outcomes of Advanced NSCLC Patients with Exon 19 or 21 EGFR Mutations
    Winfree, K.
    Molife, C.
    Peterson, P.
    Chen, Y.
    Visseren, C.
    Beyrer, J.
    Leusch, M.
    Dimou, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S23 - S23
  • [9] Real-World Outcomes of Advanced NSCLC Patients with Common and Uncommon/Complex EGFR Mutation Profiles
    Riely, G.
    Lovly, C.
    Messina, C.
    Bienert, S.
    Alexander, K.
    Pao, W.
    Magee, K.
    Baxi, S.
    Doebele, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S365 - S366
  • [10] Real-world Experience of the Utility in Afatinib Therapy for Patients with EGFR-Mutant Advanced NSCLC
    Igawa, S.
    Ono, T.
    Kasajima, M.
    Yamada, K.
    Oguri, A.
    Kameda, A.
    Yamamoto, H.
    Kakegawa, M.
    Hiyoshi, Y.
    Kusuhara, S.
    Ozawa, T.
    Otani, S.
    Fukui, T.
    Mitsufuji, H.
    Masaru, K.
    Yokoba, M.
    Kubota, M.
    Sasaki, J.
    Naoki, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S611 - S611